The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

neotis.co.kr

Stage

Other Investors | Alive

About Korea Research Institute of Bioscience and Biotechnology

Korea Research Institute of Bioscience and Biotechnology (KRIBB) works on establishing a system for large-scale integrated utilization of microbial resources through increasing value in response to demand, strain production, and characteristic information analysis for previously secured microbial resources are being conducted. It is based in Daejeon, South Korea.

Korea Research Institute of Bioscience and Biotechnology Headquarter Location

Daejeon, 34141,

South Korea

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Korea Research Institute of Bioscience and Biotechnology Patents

Korea Research Institute of Bioscience and Biotechnology has filed 53 patents.

The 3 most popular patent topics include:

  • Transcription factors
  • Clusters of differentiation
  • Rare diseases
patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/9/2020

5/3/2022

Bacterial diseases, Antibiotics, Inflammations, Infectious diseases, Moraxellaceae

Grant

Application Date

11/9/2020

Grant Date

5/3/2022

Title

Related Topics

Bacterial diseases, Antibiotics, Inflammations, Infectious diseases, Moraxellaceae

Status

Grant

Latest Korea Research Institute of Bioscience and Biotechnology News

South Korean researchers develop blood test platform to detect Alzheimer’s

May 12, 2022

PUBLISHED :May 12, 2022 - 09:06 UPDATED :May 12, 2022 - 09:06 The diagnosis platform lights up as the sample blood tests positive for Alzheimer’s disease. (Korea Research Institute of Bioscience and Biotechnology) South Korean researchers have developed a diagnosis platform using blood testing to detect early-stage Alzheimer’s disease, the Korea Research Institute of Bioscience and Biotechnology said Wednesday. To date, there is no cure for Alzheimer’s disease, a type of senile dementia leading to memory loss and cognitive impairment. The KRIBB said the key to treatment is to slow the progression of the disease through accurate early diagnosis. The researchers confirmed that the level of miR-574, a type of microRNA, increased significantly in patients with Alzheimer’s disease. In order to effectively detect the level of miR-574, they came up with a hydrogel-based sensor with catalytic hairpin assembly reaction-based probes that can detect genes at a high sensitivity without additional processes. The researchers designed the sensor in a way that it would emit fluorescent light when the Alzheimer’s disease-related biomarker is detected. The KRIBB said the traditional diagnosis of Alzheimer’s disease tested certain types of proteins to detect the disorder, but it put a burden on patients, as it required cerebrospinal fluid. The research on microRNA detection is being actively carried out in order to replace the existing method of diagnosis, it added. “The great thing is that it can detect biomarkers for Alzheimer’s disease with only blood. We expect (the diagnosis platform) to contribute to the improvement of national health and welfare in the aging era by using it in the fields of initial diagnosis and prognosis monitoring of senile dementia,” said Dr. Lim Eun-kyung, co-director of the research project. Researchers test a diagnosis platform for Alzheimer’s disease using blood. (Korea Research Institute of Bioscience and Biotechnology) By Kan Hyeong-woo ( hwkan@heraldcorp.com )

  • Where is Korea Research Institute of Bioscience and Biotechnology's headquarters?

    Korea Research Institute of Bioscience and Biotechnology's headquarters is located at Daejeon.

  • What is Korea Research Institute of Bioscience and Biotechnology's latest funding round?

    Korea Research Institute of Bioscience and Biotechnology's latest funding round is Other Investors.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.